Moderna Shares Are Trading Lower. The Company Earlier Announced Phase 3 MRNA-1083 Trial Data, Which Met Its Primary Endpoint.
Moderna Shares Are Trading Lower. The Company Earlier Announced Phase 3 MRNA-1083 Trial Data, Which Met Its Primary Endpoint.
Moderna股價下跌。該公司早些時候宣佈了第三期MRNA-1083試驗數據，達到了主要終點。
Moderna Shares Are Trading Lower. The Company Earlier Announced Phase 3 MRNA-1083 Trial Data, Which Met Its Primary Endpoint.
Moderna股價下跌。該公司早些時候宣佈了第三期MRNA-1083試驗數據，達到了主要終點。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。